Citation Impact
Citing Papers
Meta‐analysis: esomeprazole or rabeprazole vs. first‐generation pump inhibitors in the treatment of H elicobacter pylori infection
2012
Review article: the global emergence of Helicobacter pylori antibiotic resistance
2015
Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration.
1998
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Role of osteopontin in the pathophysiology of cancer
2014
Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1
1999
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
Five-year sequential changes in secondary antibiotic resistance ofHelicobacter pyloriin Taiwan
2015
Prevention of infections by probiotics
2005
Double‐Dose, New‐Generation Proton Pump Inhibitors Do Not Improve Helicobacter pylori Eradication Rate
2007
Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials
2016
Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori Infection
2009
Liver fibrosis – from bench to bedside
2003 Standout
Detection ofLactobacillus gasseriOLL2716 strain administered with yogurt drink in gastric mucus layer in humans
2006
Probiotics inHelicobacter pylorieradication therapy: A systematic review and meta-analysis
2015
High Helicobacter pylori Resistance to Metronidazole but Zero or Low Resistance to Clarithromycin, Levofloxacin, and Other Antibiotics in Malaysia
2011
Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A
2005
Hypervirulent (hypermucoviscous)Klebsiella pneumoniae
2013 Standout
Posterior capsule opacification
1992 Standout
Tumor-associated macrophages: a molecular perspective
2002
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Effect of oral esomeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers
2006
Potential of p38 MAP kinase inhibitors in the treatment of cancer
2003
Angiogenesis in health and disease
2003 Standout
Improved Eradication Rate of Standard Triple Therapy by Adding Bismuth and Probiotic Supplement for Helicobacter pylori Treatment in Thailand
2014
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
High Level of Antimicrobial Resistance in French Helicobacter pylori Isolates
2010
The chemokine system in diverse forms of macrophage activation and polarization
2004 Standout
Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: Evidence from clinical and pharmacokinetic data
2005
The Effect of CYP2C19 Polymorphisms on H. pylori Eradication Rate in Dual and Triple First-Line PPI Therapies: A Meta-analysis
2006
Extracellular matrix structure
2015 Standout
Probiotics‐Containing Yogurts Suppress Helicobacter pylori Load and Modify Immune Response and Intestinal Microbiota in the Helicobacter pylori‐Infected Children
2012
Meta‐Analysis: Lactobacillus Containing Quadruple Therapy Versus Standard Triple First‐Line Therapy for Helicobacter pylori Eradication
2009
Pyroptosis: mechanisms and diseases
2021 Standout
High-Throughput Screening of Potassium-Competitive Acid Blockers
2011
Macrophages and cancer
2008
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
2000 Standout
The Evolution of Helicobacter pylori Antibiotics Resistance Over 10 Years in Beijing, China
2010
Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan
2012
Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential
2005 Standout
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Management of Patients With Ulcer Bleeding
2012 Standout
Gut microbiota and Covid-19- possible link and implications
2020 Standout
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design
2010
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
A potential role of macrophage activation in the treatment of cancer
2002
Influence of diet on the gut microbiome and implications for human health
2017 Standout
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial
2009
Two-decade trends in primary Helicobacter pylori resistance to antibiotics in Bulgaria
2010
A review of rescue regimens after clarithromycin-containing triple therapy failure (forHelicobacter pylorieradication)
2013
Effect of CYP2C19 Genetic Polymorphisms on the Efficacy of Proton Pump Inhibitor‐Based Triple Therapy for Helicobacter pylori Eradication: A Meta‐Analysis
2008
Meta-Analysis of the Efficacy and Safety of Lactobacillus-containing and Bifidobacterium-containing Probiotic Compound Preparation in Helicobacter pylori Eradication Therapy
2012
Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular localization
2004 Standout
Randomized Comparison of Two Nonbismuth-Containing Rescue Therapies for Helicobacter pylori
2011
Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A meta-analysis
2015
Protective and pathogenic functions of macrophage subsets
2011 Standout
The Effect of Probiotics Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis
2014
Rhegmatogenous Retinal Detachment after YAG Laser Posterior Capsulotomy
1987
Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori
2013
Guidelines for treatment ofHelicobacter pyloriin the East and West
2011
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Helicobacters and Extragastric Diseases
2009
Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection
2010
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
2017
Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection
2009
Effects of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality in Subgroups
2014
Exploring the full spectrum of macrophage activation
2008 Standout
Levofloxacin/amoxicillin-based schemesvsquadruple therapy forHelicobacter pylorieradication in second-line
2012
Meta‐analysis: high‐dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication
2008
The pros, cons, and many unknowns of probiotics
2019 Standout
Macrophage activation and polarization
2007 Standout
Meta‐analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy
2006
Effects of CYP2C19 Loss-of-Function Variants on the Eradication of H. pylori Infection in Patients Treated with Proton Pump Inhibitor-Based Triple Therapy Regimens: A Meta-Analysis of Randomized Clinical Trials
2013
Molecular Detection of Helicobacter pylori and its Antimicrobial Resistance in Brazzaville, Congo
2015
Probiotics in aquaculture: Challenges and outlook
2008 Standout
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Cumulative H. pylori Eradication Rates in Clinical Practice by Adopting First and Second-Line Regimens Proposed by the Maastricht III Consensus and a Third-Line Empirical Regimen
2008
De Novo Chemoattractants Form Supramolecular Hydrogels for Immunomodulating Neutrophils In Vivo
2014
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
The Efficacy of Second‐Line Anti‐Helicobacter pylori Therapy Using an Extended 14‐Day Levofloxacin/Amoxicillin/Proton‐Pump Inhibitor Treatment – A Pilot Study
2012
Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
2014 Standout
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding
2010
Recurring Klebsiella pneumoniae Pyogenic Liver Abscesses in a Resident of San Diego, California, Due to a K1 Strain Carrying the Virulence Plasmid
2011
Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations
2016
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Is H elicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?
2012
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Prevalence of Primary and Secondary Antimicrobial Resistance of H elicobacter pylori in K orea from 2003 through 2012
2012
Alternative Activation of Macrophages: An Immunologic Functional Perspective
2008 Standout
Scavenger-Receptor Targeted Photodynamic Therapy¶
2000
Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-LineHelicobacter pyloriEradication
2015
Hypoxia Selectively Inhibits Monocyte Chemoattractant Protein-1 Production by Macrophages
2004
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication
2008
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Synthesis and biological activity of pyrrole, pyrroline and pyrrolidine derivatives with two aryl groups on adjacent positions
2006 Standout
Lactobacillus -containing probiotic supplementation increases Helicobacter pylori eradication rate: evidence from a meta-analysis
2013
Works of Hsiu‐Chi Cheng being referenced
Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion.
2003
Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy
2006
Gemifloxacin Can Partially Overcome Quinolone Resistance of H. pylori with gyrA Mutation in Taiwan
2012
H. pylori cagL amino acid sequence polymorphism Y58E59 induces a corpus shift of gastric integrin α5β1 related with gastric carcinogenesis
2011
Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism
2005
Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin‐based therapy in Taiwan
2009
Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapy
2005
Long-term Outcome of Pyogenic Liver Abscess
2008
The Efficacy of High- and Low-Dose Intravenous Omeprazole in Preventing Rebleeding for Patients with Bleeding Peptic Ulcers and Comorbid Illnesses
2005
Increased Gastric Osteopontin Expression by Helicobacter pylori Infection can Correlate with More Severe Gastric Inflammation and Intestinal Metaplasia
2011
Gender Difference of Circulating Ghrelin and Leptin Concentrations in Chronic Helicobacter pylori Infection
2009
Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits Hsiu-Chi Cheng, Bor-Shyang Sheu
2011
Levofloxacin‐Containing Triple Therapy to Eradicate the Persistent H. pylori after a Failed Conventional Triple Therapy
2007
Freeze frame analysis on high speed cinematography of Nd/YAG laser explosions in ocular tissues.
1986
The pattern of monocyte recruitment in tumors is modulated by MCP-1 expression and influences the rate of tumor growth.
1997
The corpus‐predominant gastritis index may serve as an early marker of Helicobacter pylori‐infected patients at risk of gastric cancer
2013
Effect of 4% Chlorhexidine Gluconate Predisinfection Skin Scrub Prior to Hepatectomy: A Double-Blinded, Randomized Control Study
2014